No Detail Found!

Drugs affecting renin-angiotensin-aldosterone system and the cancer risk: A meta-analysis of nested case-control studies

Author(s)
Liu Dong-mei Oncology Department of Yulin First Hospital, Second Affiliated Hospital of Yanan University,Yulin Shaanxi,PR China
Zhang Wei Pharmacy Department of Yulin First Hospital, Second Affiliated Hospital of Yanan University,Yulin Shaanxi,PR China
Hao Guang-jun Oncology Department of Yulin First Hospital, Second Affiliated Hospital of Yanan University,Yulin Shaanxi,PR China
James Lu Foreign Languages Institute of Yulin University,Yulin Shannxi,PR China
Han Jian-lun Cardiology Department of Yulin First Hospital, Second Affiliated Hospital of Yanan University,Yulin Shaanxi,PR China
Zhang Jian Cardiology Department of Yulin First Hospital, Second Affiliated Hospital of Yanan University,Yulin Shaanxi,PR China
Abstract
Multiple studies have discussed the associations between drugs affecting the renin-angiotensin-aldosterone system and the cancer risk, but their consequence s were conflicting. A meta-analysis of nested case-control studies published regarding this subject was conducted in our study, aims to estimate the association between ACEI/ARB and the cancer risk. Pubmed database was searched up to February, 1 2016 to identify eligible nested case-control studies, and we used Newcastle-Ottawa Scale (NOS) to assess quality of the studies. Pooled odds ratio (OR) and 95% confidence intervals (CIs) were calculated (with fixed effect model: Mantel-Haenszel). Publication bias and heterogeneity were evaluated before the calculation. Subgroup analysis and sensitivity analysis were also performed. Seven studies contributed to the analysis. Overall, ACEI/ARB use was not associated with the risk of cancer (OR=0.99, 95% CI 0.971.01), nor in long-term use patients (OR=0.97, 95% CI 0.92-1.01). ACEI may decrease cancer risk (OR=0.90, 95% CI 0.82-0.99). We observed no significant publication bias. In conclusion, ACEI/ARB use was not associated with cancer risk, nor in long-term use patients, but ACEI use may decrease cancer risk. More researches are needed to confirm these findings.
Publication Details
Page(s) 35-39
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
Cancer, ACEI, case-control studies, meta analysis, nested
0

Citations

0

Downloads

66

Views